newsfilter
← Latest News
GlobeNewswire·

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

ME

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and preventive health company, reported its financial results for the second quarter of fiscal year 2025